1996
DOI: 10.1074/jbc.271.16.9403
|View full text |Cite
|
Sign up to set email alerts
|

Two Distinct Intracytoplasmic Regions of the T-cell Adhesion Molecule CD28 Participate in Phosphatidylinositol 3-Kinase Association

Abstract: Through the interaction with its ligands, CD80/B7-1 and CD86/B7-2 or B70, the human CD28 molecule plays a major functional role as a costimulator of T cells along with the CD3-TcR complex. We and others have previously reported that phosphatidylinositol 3-kinase inducibly associates with CD28. This association is mediated by the SH2 domains of the p85 adaptor subunit interacting with a cytoplasmic YMNM consensus motif present in CD28 at position 173-176. Disruption of this binding site by site-directed mutagen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
55
0

Year Published

1997
1997
2008
2008

Publication Types

Select...
10

Relationship

4
6

Authors

Journals

citations
Cited by 60 publications
(63 citation statements)
references
References 46 publications
8
55
0
Order By: Relevance
“…Therefore, CTLA-4 and CD28 appear to share a common target in intracellular signaling. This is consistent with our previous observation that both receptors bind to PI3-K (14,36,37). In fact, PI3-kinase is required for JNK activation (38).…”
Section: Resultssupporting
confidence: 93%
“…Therefore, CTLA-4 and CD28 appear to share a common target in intracellular signaling. This is consistent with our previous observation that both receptors bind to PI3-K (14,36,37). In fact, PI3-kinase is required for JNK activation (38).…”
Section: Resultssupporting
confidence: 93%
“…The YMNM and the C-terminal YQPYAPP motif have been involved in the activation of both NF-jB [18,20] and, as previously demonstrated by Pages et al [21], in PI3K binding to CD28. Consistently, pre-treatment of J1G5 cells with a specific PI3K inhibitor (LY294002), before activation with Dap3/B7 cells, completely inhibited the recruitment of RelA on the HIV-1 LTR, similarly to the proteasome and NF-jB inhibitor MG132 (Fig.…”
Section: Resultssupporting
confidence: 57%
“…Human CD28 insert (SalI-BamHI) was excised from pH␤Apr-1-neo-CD28WT (43), and replaced with a truncated human CD28 sequence lacking the cytoplasmic tail (plasmid pHsCD28⌬30). The cytoplasmic tails of rbtCD28 or rbtCTLA4 were then inserted in-frame with the extracellular portion of human CD28 to generate chimeric proteins, where the human cytoplasmic tail was replaced by rainbow trout CD28 or CTLA4 cytoplasmic tails (plasmids phuCD28-rbtCD28 and phuCD28-rbtCTLA4, respectively).…”
Section: Plasmids and Cell Linesmentioning
confidence: 99%